PharmaNet Development Group is pleased to announce that it is hosting a Phase IV symposia entitled "Safety and Value: Critical Success Factors for Post-Approval Research".

Key note speakers from companies such as PharmaNet, Eisai Europe and Abacus International will all be presenting during the event.

Featured topics include:

• Strategic Post-Approval Research Planning
• The Evolving Post-Approval Regulatory Environment in Europe
• Issues in Safety
• Epidemiology and Risk Management
• Obtaining Real-World Evidence through Observational Research and Patient Registries
• Establishing Product Value through Health Economies and Outcomes Research (HEOR)
• Post-Approval Case Studies

About PharmaNet Development Group
PharmaNet Development Group, Inc., a global drug development services company, provides a comprehensive range of services to the pharmaceutical, biotechnology, generic drug and medical device industries. The company offers early and late stage consulting, Phase I clinical studies and bioanalytical analyses, and Phase II, III and IV clinical development programs. With approximately 2300 employees in 33 countries and more than 40 facilities throughout the world, PharmaNet is a recognized leader in outsources clinical development.

Click here for more information